Article
By-passing in vitro screening—next generation sequencing technologies applied to antibody display and in silico candidate selection
15 Sept 2010
Abstract excerpt
In recent years, unprecedented DNA sequencing capacity provided by next generation sequencing (NGS) has revolutionized genomic research. Combining the Illumina sequencing platform and a scFv library designed to confine diversity to both CDR3, >1.9 × 10(7) sequences have been generated. This approach allowed for in depth analysis of the library's diversity, provided sequence information on virtually all scFv...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
